[S02DA03, antipyrine, Antipyrine may decrease the antihypertensive activities of Hydralazine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Hydralazine.]
[J01GA01, streptomycin, Hydralazine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01CG01, sulbactam, Hydralazine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Sulfamethoxazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M01AB02, sulindac, Sulindac may decrease the antihypertensive activities of Hydralazine.]
[M01AX04, apazone, Azapropazone may decrease the antihypertensive activities of Hydralazine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Hydralazine.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Hydralazine.]
[R03CC03, terbutaline, Terbutaline may decrease the antihypertensive activities of Hydralazine.]
[B01AE07, dabigatran etexilate, Hydralazine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AE05, lurasidone, Lurasidone may decrease the antihypertensive activities of Hydralazine.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Hydralazine.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydralazine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Thalidomide is combined with Hydralazine.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Hydralazine.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Hydralazine.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Hydralazine.]
[N05AB08, thioproperazine, Thioproperazine may decrease the antihypertensive activities of Hydralazine.]
[N05AC02, thioridazine, Thioridazine may decrease the antihypertensive activities of Hydralazine.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Hydralazine.]
[N05AL03, tiapride, Hydralazine may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01ED01, timolol, Timolol may increase the hypotensive activities of Hydralazine.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01AA12, tobramycin, Hydralazine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M02AX02, tolazoline, Tolazoline may decrease the antihypertensive activities of Hydralazine.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the antihypertensive activities of Hydralazine.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Hydralazine.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the hypotensive activities of Hydralazine.]
[N06AX05, trazodone, Trazodone may decrease the antihypertensive activities of Hydralazine.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydralazine.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Hydralazine can be increased when used in combination with Trichlormethiazide.]
[A16AX12, trientine, Hydralazine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, Trifluoperazine may decrease the antihypertensive activities of Hydralazine.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[A03AA05, trimebutine, Hydralazine may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[S01ED04, metipranolol, Metipranolol may increase the hypotensive activities of Hydralazine.]
[C02BA01, trimethaphan, Trimethaphan may increase the hypotensive activities of Hydralazine.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06AA06, trimipramine, Trimipramine may decrease the antihypertensive activities of Hydralazine.]
[N06AX24, vilazodone, Vilazodone may decrease the antihypertensive activities of Hydralazine.]
[C09CA09, azilsartan medoxomil, Hydralazine may increase the hypotensive activities of Azilsartan medoxomil.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Hydralazine.]
[L01FX04, ipilimumab, Hydralazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Hydralazine.]
[R02AA14, oxyquinoline, Hydralazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be decreased when combined with Hydralazine.]
[S01AA28, vancomycin, Hydralazine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Hydralazine may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Hydralazine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, Indacaterol may decrease the antihypertensive activities of Hydralazine.]
[C08DA01, verapamil, The risk or severity of adverse effects can be increased when Verapamil is combined with Hydralazine.]
[N06AX09, viloxazine, Hydralazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Hydralazine.]
[C04AX07, vincamine, Hydralazine may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Hydralazine.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Hydralazine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Hydralazine.]
[N01AX15, xenon, Xenon may decrease the antihypertensive activities of Hydralazine.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Hydralazine.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Hydralazine.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Hydralazine.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[B06AC02, icatibant, Hydralazine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Hydralazine.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AE04, ziprasidone, Ziprasidone may increase the antihypertensive activities of Hydralazine.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Hydralazine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the antihypertensive activities of Hydralazine.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Hydralazine.]
[G04BD07, tolterodine, Tolterodine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DH04, doripenem, Hydralazine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[L01FA01, rituximab, Hydralazine may increase the hypotensive activities of Rituximab.]
[S01FA01, atropine, Atropine may decrease the antihypertensive activities of Hydralazine.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Hydralazine.]
[B03XA04, peginesatide, Hydralazine may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G04BE10, avanafil, Hydralazine may increase the hypotensive activities of Avanafil.]
[M03BX01, baclofen, The risk or severity of adverse effects can be increased when Baclofen is combined with Hydralazine.]
[A08AA11, lorcaserin, Hydralazine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Mirabegron may decrease the antihypertensive activities of Hydralazine.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Hydralazine.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Hydralazine.]
[C01CA18, octopamine, Octopamine may decrease the antihypertensive activities of Hydralazine.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Hydralazine.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Hydralazine.]
[D02BA02, octinoxate, Hydralazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Hydralazine.]
[N04BD02, rasagiline, Rasagiline may increase the hypotensive activities of Hydralazine.]
[C08CA13, lercanidipine, Lercanidipine may increase the hypotensive activities of Hydralazine.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Hydralazine.]
[N02CC03, zolmitriptan, Zolmitriptan may decrease the antihypertensive activities of Hydralazine.]
[V09IX04, fluorodeoxyglucose F18, Hydralazine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, Diethyl ether may decrease the antihypertensive activities of Hydralazine.]
[G04BE03, sildenafil, Sildenafil may increase the antihypertensive activities of Hydralazine.]
[V08CA11, gadofosveset, Hydralazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Hydralazine.]
[A16AX08, teduglutide, Hydralazine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Hydralazine.]
[A10BH04, alogliptin, Hydralazine may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Hydralazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Hydralazine can be increased when used in combination with Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Hydralazine.]
[N02BA10, benorilate, Benorilate may decrease the antihypertensive activities of Hydralazine.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AA12, ancestim, Hydralazine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the antihypertensive activities of Hydralazine.]
[N02CC02, naratriptan, Naratriptan may decrease the antihypertensive activities of Hydralazine.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Hydralazine.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01EC02, dabrafenib, The metabolism of Dabrafenib can be decreased when combined with Hydralazine.]
[R02AX03, benzydamine, Benzydamine may decrease the antihypertensive activities of Hydralazine.]
[L01EE01, trametinib, Hydralazine may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Hydralazine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Hydralazine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, Bepridil may increase the hypotensive activities of Hydralazine.]
[C02KX05, riociguat, Hydralazine may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, Hydralazine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Hydralazine may increase the hypotensive activities of Macitentan.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Hydralazine.]
[N06AX26, vortioxetine, Vortioxetine may decrease the antihypertensive activities of Hydralazine.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J05AP08, sofosbuvir, Hydralazine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Droxidopa may decrease the antihypertensive activities of Hydralazine.]
[C07AB04, acebutolol, Acebutolol may increase the hypotensive activities of Hydralazine.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Hydralazine.]
[L04AA32, apremilast, Hydralazine may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Hydralazine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, Betaxolol may increase the hypotensive activities of Hydralazine.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C02CC01, bethanidine, Bethanidine may decrease the antihypertensive activities of Hydralazine.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Hydralazine.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Hydralazine.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Hydralazine.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Hydralazine.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Hydralazine is combined with Empagliflozin.]
[R03AC19, olodaterol, Olodaterol may decrease the antihypertensive activities of Hydralazine.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01EE02, unoprostone, Hydralazine may increase the hypotensive activities of Unoprostone.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Hydralazine.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Hydralazine.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AA04, acepromazine, Acepromazine may decrease the antihypertensive activities of Hydralazine.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Hydralazine.]
[S03AA06, gentamicin, Hydralazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Hydralazine.]
[B01AF03, edoxaban, Hydralazine may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Hydralazine.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Hydralazine.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Hydralazine.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AX16, brexpiprazole, Brexpiprazole may decrease the antihypertensive activities of Hydralazine.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Hydralazine.]
[G02CX02, flibanserin, Flibanserin may decrease the antihypertensive activities of Hydralazine.]
[N05AX15, cariprazine, Cariprazine may decrease the antihypertensive activities of Hydralazine.]
[M02AA25, aceclofenac, Aceclofenac may decrease the antihypertensive activities of Hydralazine.]
[M01AB11, acemetacin, Acemetacin may decrease the antihypertensive activities of Hydralazine.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB37, idarucizumab, Hydralazine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Hydralazine.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Hydralazine.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Hydralazine.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Hydralazine.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Hydralazine.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Hydralazine.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Hydralazine.]
[B01AC27, selexipag, Hydralazine may increase the hypotensive activities of Selexipag.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Hydralazine.]
[M04AB05, lesinurad, Hydralazine may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the antihypertensive activities of Hydralazine.]
[N03AX23, brivaracetam, Hydralazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Hydralazine.]
[N05BA08, bromazepam, Hydralazine may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, Bromocriptine may decrease the antihypertensive activities of Hydralazine.]
[A02AD05, aluminum magnesium silicate, Hydralazine may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N06AA19, amineptin, Amineptine may decrease the antihypertensive activities of Hydralazine.]
[C08CA01, amlodipine, Amlodipine may increase the hypotensive activities of Hydralazine.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Hydralazine.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydralazine.]
[C07AA19, bupranolol, Hydralazine may increase the hypotensive activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the antihypertensive activities of Hydralazine.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Hydralazine.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydralazine.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Hydralazine.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Hydralazine.]
[A07EC04, balsalazide, Balsalazide may decrease the antihypertensive activities of Hydralazine.]
[R03CC12, bambuterol, Bambuterol may decrease the antihypertensive activities of Hydralazine.]
[A06AH05, naldemedine, Hydralazine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Hydralazine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C09AA07, benazepril, Benazepril may increase the hypotensive activities of Hydralazine.]
[P01CA02, benznidazole, Hydralazine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the hypotensive activities of Hydralazine.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N07XX13, valbenazine, Hydralazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Hydralazine.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Hydralazine.]
[N04BD03, safinamide, Safinamide may increase the hypotensive activities of Hydralazine.]
[J01MA23, delafloxacin, Hydralazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Hydralazine.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Hydralazine.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Hydralazine.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Hydralazine.]
[C07AB07, bisoprolol, Bisoprolol may increase the hypotensive activities of Hydralazine.]
[R03AC17, bitolterol, Bitolterol may decrease the antihypertensive activities of Hydralazine.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Hydralazine is combined with Nesiritide.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Budesonide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Hydralazine.]
[M01AB07, bumadizone, Bumadizone may decrease the antihypertensive activities of Hydralazine.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Hydralazine.]
[N06AA15, butriptyline, Butriptyline may decrease the antihypertensive activities of Hydralazine.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Hydralazine may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, Captopril may increase the hypotensive activities of Hydralazine.]
[L02BB05, apalutamide, Hydralazine may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Hydralazine.]
[C07AG02, carvedilol, Carvedilol may increase the hypotensive activities of Hydralazine.]
[B02BX09, fostamatinib, Fostamatinib may increase the antihypertensive activities of Hydralazine.]
[N03AX24, cannabidiol, Cannabidiol may decrease the antihypertensive activities of Hydralazine.]
[L04AA37, baricitinib, Hydralazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01GB14, plazomicin, Hydralazine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Hydralazine may increase the hypotensive activities of Celiprolol.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Hydralazine.]
[A16AX14, migalastat, Hydralazine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Hydralazine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Hydralazine.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Hydralazine.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[D08AE05, chloroxylenol, Hydralazine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the antihypertensive activities of Hydralazine.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Hydralazine.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Hydralazine.]
[C09AA08, cilazapril, Hydralazine may increase the hypotensive activities of Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Hydralazine.]
[A03FA08, cinitapride, Cinitapride may decrease the antihypertensive activities of Hydralazine.]
[S01ED05, carteolol, Carteolol may increase the hypotensive activities of Hydralazine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Hydralazine.]
[N06BA14, solriamfetol, Solriamfetol may decrease the antihypertensive activities of Hydralazine.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Hydralazine.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C09CA06, candesartan, Hydralazine may increase the hypotensive activities of Candesartan.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Hydralazine.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Hydralazine.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Hydralazine.]
[N07XX11, pitolisant, Hydralazine may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Hydralazine.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Hydralazine.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Hydralazine can be increased when used in combination with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the antihypertensive activities of Hydralazine.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Hydralazine.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Hydralazine.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Hydralazine.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Hydralazine.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M09AX08, golodirsen, Hydralazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Hydralazine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Hydralazine.]
[N02CC07, frovatriptan, Frovatriptan may decrease the antihypertensive activities of Hydralazine.]
[G04CB02, dutasteride, Dutasteride may decrease the antihypertensive activities of Hydralazine.]
[R02AA03, dichlorobenzyl alcohol, Hydralazine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Hydralazine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, Eletriptan may decrease the antihypertensive activities of Hydralazine.]
[M01AH02, rofecoxib, Rofecoxib may decrease the antihypertensive activities of Hydralazine.]
[C08CA16, clevidipine, The risk or severity of adverse effects can be increased when Hydralazine is combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Hydralazine.]
[C02AA06, methoserpidine, Hydralazine may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Hydralazine is combined with Opicapone.]
[C01CA14, dopexamine, Dopexamine may decrease the antihypertensive activities of Hydralazine.]
[M01AC04, droxicam, Droxicam may decrease the antihypertensive activities of Hydralazine.]
[V08CA05, mangafodipir, Hydralazine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Hydralazine.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the antihypertensive activities of Hydralazine.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Hydralazine.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Hydralazine.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Hydralazine can be increased when used in combination with Chlorothiazide.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Hydralazine.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the antihypertensive activities of Hydralazine.]
[N02BA03, choline salicylate, Hydralazine may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, Etodolac may decrease the antihypertensive activities of Hydralazine.]
[M02AA06, etofenamate, Etofenamate may decrease the antihypertensive activities of Hydralazine.]
[M01AX25, chondroitin sulfates, Hydralazine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Hydralazine.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Hydralazine is combined with Vericiguat.]
[M01AE05, fenbufen, Fenbufen may decrease the antihypertensive activities of Hydralazine.]
[C01CA19, fenoldopam, Fenoldopam may increase the hypotensive activities of Hydralazine.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Hydralazine.]
[G04CB01, finasteride, Finasteride may decrease the antihypertensive activities of Hydralazine.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02BG07, flupirtine, Hydralazine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, Formoterol may decrease the antihypertensive activities of Hydralazine.]
[N01AB05, trichloroethylene, Trichloroethylene may decrease the antihypertensive activities of Hydralazine.]
[H04AA02, dasiglucagon, Hydralazine may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Hydralazine.]
[S03AA07, ciprofloxacin, Ciprofloxacin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01XA01, cisplatin, Hydralazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Hydralazine.]
[V09AB03, ioflupane I-123, Hydralazine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Hydralazine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Hydralazine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R03CC13, clenbuterol, Clenbuterol may decrease the antihypertensive activities of Hydralazine.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Hydralazine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Hydralazine.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01EA04, clonidine, The risk or severity of hypotension can be increased when Clonidine is combined with Hydralazine.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Clozapine may decrease the antihypertensive activities of Hydralazine.]
[J01GB12, arbekacin, Hydralazine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, The therapeutic efficacy of Hydralazine can be decreased when used in combination with Cocaine.]
[C02KB01, metyrosine, Metyrosine may increase the hypotensive activities of Hydralazine.]
[M01AX13, proquazone, Proquazone may decrease the antihypertensive activities of Hydralazine.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Hydralazine.]
[J01XB01, colistin, Hydralazine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N01AB07, desflurane, Desflurane may decrease the antihypertensive activities of Hydralazine.]
[A04AA03, tropisetron, Hydralazine may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, Ifenprodil may decrease the antihypertensive activities of Hydralazine.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the antihypertensive activities of Hydralazine.]
[B01AC10, indobufen, Indobufen may decrease the antihypertensive activities of Hydralazine.]
[J05AB14, valganciclovir, Hydralazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Hydralazine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[V08AB05, iopromide, Hydralazine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Hydralazine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Hydralazine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the antihypertensive activities of Hydralazine.]
[A03AX10, isometheptene, Isometheptene may decrease the antihypertensive activities of Hydralazine.]
[N02CC05, almotriptan, Almotriptan may decrease the antihypertensive activities of Hydralazine.]
[M01AH04, parecoxib, Parecoxib may decrease the antihypertensive activities of Hydralazine.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05BA10, ketazolam, Hydralazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the antihypertensive activities of Hydralazine.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Hydralazine.]
[S01EE03, bimatoprost, Bimatoprost may increase the hypotensive activities of Hydralazine.]
[C08CA09, lacidipine, Hydralazine may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N07BC04, lofexidine, Lofexidine may decrease the antihypertensive activities of Hydralazine.]
[M01AB09, lonazolac, Lonazolac may decrease the antihypertensive activities of Hydralazine.]
[M02AA31, loxoprofen, Loxoprofen may decrease the antihypertensive activities of Hydralazine.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may increase the hypotensive activities of Hydralazine.]
[A06AD01, magnesium carbonate, Hydralazine may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Hydralazine may increase the hypotensive activities of Manidipine.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Hydralazine.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the antihypertensive activities of Hydralazine.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Hydralazine may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Hydralazine can be increased when used in combination with Cyclopenthiazide.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Hydralazine.]
[N06AX07, minaprine, Minaprine may increase the hypotensive activities of Hydralazine.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Hydralazine.]
[N06AG02, moclobemide, Moclobemide may increase the hypotensive activities of Hydralazine.]
[C09AA13, moexipril, Moexipril may increase the hypotensive activities of Hydralazine.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Hydralazine.]
[M02AA02, mofebutazone, Mofebutazone may decrease the antihypertensive activities of Hydralazine.]
[M01AX22, morniflumate, Morniflumate may decrease the antihypertensive activities of Hydralazine.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be decreased when combined with Hydralazine.]
[C02AC05, moxonidine, Moxonidine may decrease the antihypertensive activities of Hydralazine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Hydralazine.]
[M01AH05, etoricoxib, Etoricoxib may decrease the antihypertensive activities of Hydralazine.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C02CC04, debrisoquin, Hydralazine may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Hydralazine.]
[M01AX01, nabumetone, Nabumetone may decrease the antihypertensive activities of Hydralazine.]
[N07BB05, nalmefene, Hydralazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, Hydralazine may increase the hypotensive activities of Nebivolol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may decrease the antihypertensive activities of Hydralazine.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Hydralazine.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01CA23, theodrenaline, Theodrenaline may decrease the antihypertensive activities of Hydralazine.]
[C01CA05, norfenefrine, Norfenefrine may decrease the antihypertensive activities of Hydralazine.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G04BD08, solifenacin, Solifenacin may decrease the antihypertensive activities of Hydralazine.]
[A07EC03, olsalazine, Olsalazine may decrease the antihypertensive activities of Hydralazine.]
[N06AA01, desipramine, Desipramine may decrease the antihypertensive activities of Hydralazine.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Hydralazine.]
[V04CH02, indigo carmine, Hydralazine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C09XA02, aliskiren, Hydralazine may increase the hypotensive activities of Aliskiren.]
[M01AE12, oxaprozin, Oxaprozin may decrease the antihypertensive activities of Hydralazine.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the antihypertensive activities of Hydralazine.]
[P03AC04, permethrin, Hydralazine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Hydralazine.]
[N06AA08, dibenzepin, Dibenzepin may decrease the antihypertensive activities of Hydralazine.]
[R05DA08, pholcodine, Hydralazine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the antihypertensive activities of Hydralazine.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C02DG01, pinacidil, Hydralazine may increase the hypotensive activities of Pinacidil.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Hydralazine is combined with Pipamperone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Hydralazine.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Hydralazine.]
[R03CC07, pirbuterol, Pirbuterol may decrease the antihypertensive activities of Hydralazine.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, Diethylpropion may decrease the antihypertensive activities of Hydralazine.]
[C08CA03, isradipine, Isradipine may increase the hypotensive activities of Hydralazine.]
[D07XC04, diflucortolone, Hydralazine may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the antihypertensive activities of Hydralazine.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Hydralazine.]
[C01AA05, digoxin, Hydralazine may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Hydralazine may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Hydralazine.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Hydralazine.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Atazanavir can be decreased when combined with Hydralazine.]
[B01AC21, treprostinil, Treprostinil may increase the hypotensive activities of Hydralazine.]
[H03BC01, potassium perchlorate, Hydralazine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C08DB01, diltiazem, Diltiazem may increase the hypotensive activities of Hydralazine.]
[V03AB09, dimercaprol, Hydralazine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, Procaterol may decrease the antihypertensive activities of Hydralazine.]
[M02AX03, dimethyl sulfoxide, Dimethyl sulfoxide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the antihypertensive activities of Hydralazine.]
[M01AB14, proglumetacin, Proglumetacin may decrease the antihypertensive activities of Hydralazine.]
[C09AA06, quinapril, Quinapril may increase the hypotensive activities of Hydralazine.]
[B01AC07, dipyridamole, Dipyridamole may increase the antihypertensive activities of Hydralazine.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may decrease the antihypertensive activities of Hydralazine.]
[N06AA23, quinupramine, Quinupramine may decrease the antihypertensive activities of Hydralazine.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Hydralazine.]
[C09AA05, ramipril, Ramipril may increase the hypotensive activities of Hydralazine.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Hydralazine.]
[R03CC14, reproterol, Reproterol may decrease the antihypertensive activities of Hydralazine.]
[S01AX06, resorcinol, Hydralazine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AX08, risperidone, Hydralazine may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, Hydralazine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Hydralazine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Hydralazine.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Hydralazine.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Hydralazine.]
[G04BE08, tadalafil, Tadalafil may increase the hypotensive activities of Hydralazine.]
[S01BC05, ketorolac, Ketorolac may decrease the antihypertensive activities of Hydralazine.]
[C02KX02, ambrisentan, Hydralazine may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the antihypertensive activities of Hydralazine.]
[R03AC12, salmeterol, Salmeterol may decrease the antihypertensive activities of Hydralazine.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the antihypertensive activities of Hydralazine.]
[C01CA04, dopamine, Dopamine may decrease the antihypertensive activities of Hydralazine.]
[N06AA16, dothiepin, Dosulepin may decrease the antihypertensive activities of Hydralazine.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Hydralazine.]
[N06AA12, doxepin, Doxepin may decrease the antihypertensive activities of Hydralazine.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Hydralazine.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N01AB08, sevoflurane, Sevoflurane may decrease the antihypertensive activities of Hydralazine.]
[N05AD08, droperidol, Droperidol may decrease the antihypertensive activities of Hydralazine.]
[A08AA10, sibutramine, Sibutramine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Hydralazine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, Hydralazine may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the antihypertensive activities of Hydralazine.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C07AB13, talinolol, Hydralazine may increase the hypotensive activities of Talinolol.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the antihypertensive activities of Hydralazine.]
[G04CA03, terazosin, Terazosin may increase the hypotensive activities of Hydralazine.]
[S01GA02, tetrahydrozoline, Tetryzoline may decrease the antihypertensive activities of Hydralazine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Hydralazine.]
[C09AA02, enalapril, Enalapril may increase the hypotensive activities of Hydralazine.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the antihypertensive activities of Hydralazine.]
[N06AG03, toloxatone, Toloxatone may increase the hypotensive activities of Hydralazine.]
[N06BA09, atomoxetine, Atomoxetine may decrease the antihypertensive activities of Hydralazine.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Hydralazine.]
[C09AA10, trandolapril, Trandolapril may increase the hypotensive activities of Hydralazine.]
[N05CC01, chloral hydrate, Hydralazine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[R03CC11, tulobuterol, Tulobuterol may decrease the antihypertensive activities of Hydralazine.]
[C02CA06, urapidil, Urapidil may decrease the antihypertensive activities of Hydralazine.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Hydralazine.]
[S01FB02, ephedrine, Ephedrine may decrease the antihypertensive activities of Hydralazine.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01CX07, xamoterol, Xamoterol may decrease the antihypertensive activities of Hydralazine.]
[S01GA03, xylometazoline, Xylometazoline may decrease the antihypertensive activities of Hydralazine.]
[C08CA12, mepirodipine, Hydralazine may increase the antihypertensive activities of Barnidipine.]
[S01EA01, epinephrine, Epinephrine may decrease the antihypertensive activities of Hydralazine.]
[C09AA15, zofenopril, Hydralazine may increase the hypotensive activities of Zofenopril.]
[M01AB04, zomepirac, Zomepirac may decrease the antihypertensive activities of Hydralazine.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Hydralazine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the antihypertensive activities of Hydralazine.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Hydralazine.]
[G02AB03, ergonovine, Ergometrine may decrease the antihypertensive activities of Hydralazine.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may decrease the antihypertensive activities of Hydralazine.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Hydralazine.]
[L03AX05, pidotimod, Hydralazine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Estazolam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01CA15, gepefrine, Gepefrine may decrease the antihypertensive activities of Hydralazine.]
[V03AF05, amifostine, Hydralazine may increase the hypotensive activities of Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M01AC06, meloxicam, Meloxicam may decrease the antihypertensive activities of Hydralazine.]
[C01CA01, etilefrine, Etilefrine may decrease the antihypertensive activities of Hydralazine.]
[N01AX07, etomidate, Etomidate may decrease the antihypertensive activities of Hydralazine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Hydralazine.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Hydralazine.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Hydralazine.]
[R06AX12, terfenadine, The metabolism of Terfenadine can be decreased when combined with Hydralazine.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Hydralazine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Hydralazine may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Hydralazine.]
[C08CA02, felodipine, Felodipine may increase the hypotensive activities of Hydralazine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the antihypertensive activities of Hydralazine.]
[R03CC04, fenoterol, Fenoterol may decrease the antihypertensive activities of Hydralazine.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Hydralazine.]
[R03CC02, albuterol, Salbutamol may decrease the antihypertensive activities of Hydralazine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Hydralazine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G04BD02, flavoxate, Flavoxate may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the antihypertensive activities of Hydralazine.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06AA14, melitracen, Melitracen may decrease the antihypertensive activities of Hydralazine.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Hydralazine.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AF01, flupenthixol, Flupentixol may decrease the antihypertensive activities of Hydralazine.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the antihypertensive activities of Hydralazine.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01BC03, tegafur, Hydralazine may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[N06BX17, adrafinil, Adrafinil may decrease the antihypertensive activities of Hydralazine.]
[G01AX06, furazolidone, Furazolidone may increase the hypotensive activities of Hydralazine.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Hydralazine.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Hydralazine.]
[C10AB04, gemfibrozil, Gemfibrozil may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01XA03, telavancin, Hydralazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Hydralazine.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Hydralazine.]
[N01AH02, alfentanil, Alfentanil may decrease the antihypertensive activities of Hydralazine.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the antihypertensive activities of Hydralazine.]
[C05AE01, nitroglycerin, Nitroglycerin may increase the hypotensive activities of Hydralazine.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Hydralazine.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Hydralazine.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Hydralazine.]
[C07AB09, esmolol, Esmolol may increase the hypotensive activities of Hydralazine.]
[M01CB04, aurothioglucose, Hydralazine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Hydralazine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may increase the hypotensive activities of Hydralazine.]
[S01EX01, guanethidine, Guanethidine may increase the hypotensive activities of Hydralazine.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Hydralazine.]
[N01AB01, halothane, Halothane may decrease the antihypertensive activities of Hydralazine.]
[N05AH04, quetiapine, Quetiapine may increase the hypotensive activities of Hydralazine.]
[N06BX13, idebenone, Hydralazine may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Hydralazine.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C09CA01, losartan, Losartan may increase the hypotensive activities of Hydralazine.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Hydralazine.]
[A07EC02, mesalamine, Mesalazine may decrease the antihypertensive activities of Hydralazine.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Hydralazine.]
[R03CC05, hexoprenaline, Hexoprenaline may decrease the antihypertensive activities of Hydralazine.]
[C08CA10, nilvadipine, Hydralazine may increase the hypotensive activities of Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the antihypertensive activities of Hydralazine.]
[C09AA04, perindopril, Perindopril may increase the hypotensive activities of Hydralazine.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the antihypertensive activities of Hydralazine.]
[C01DA05, pentaerythritol tetranitrate, Hydralazine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Hydralazine can be increased when used in combination with Hydroflumethiazide.]
[B05XA17, potassium acetate, Hydralazine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G04BD06, propiverine, Propiverine may decrease the antihypertensive activities of Hydralazine.]
[B05AA07, hetastarch, Hydralazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[C02AC06, rilmenidine, Rilmenidine may decrease the antihypertensive activities of Hydralazine.]
[R02AX02, ibuprofen, Ibuprofen may decrease the antihypertensive activities of Hydralazine.]
[B05XA08, sodium acetate, Hydralazine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Hydralazine.]
[N01AH03, sufentanil, Sufentanil may decrease the antihypertensive activities of Hydralazine.]
[N06AA02, imipramine, Imipramine may decrease the antihypertensive activities of Hydralazine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Hydralazine.]
[R01AD07, tixocortol, Hydralazine may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Hydralazine.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be increased when used in combination with Hydralazine.]
[S01BC01, indomethacin, Indomethacin may decrease the antihypertensive activities of Hydralazine.]
[C02CA02, indoramin, Indoramin may decrease the antihypertensive activities of Hydralazine.]
[A11HA07, inositol, Hydralazine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Hydralazine may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[A10BH01, sitagliptin, Sitagliptin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Hydralazine.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C07AA01, alprenolol, Alprenolol may increase the hypotensive activities of Hydralazine.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Hydralazine may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AA13, iprindole, Iprindole may decrease the antihypertensive activities of Hydralazine.]
[N06AF05, iproniazid, Iproniazid may increase the hypotensive activities of Hydralazine.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypotensive activities of Hydralazine.]
[S01EC03, dorzolamide, Dorzolamide may increase the hypotensive activities of Hydralazine.]
[R03CC06, isoetharine, Isoetharine may decrease the antihypertensive activities of Hydralazine.]
[C09AA16, imidapril, Hydralazine may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may decrease the antihypertensive activities of Hydralazine.]
[J04AC01, isoniazid, Isoniazid may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J05AX05, inosine pranobex, Hydralazine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, Isoprenaline may decrease the antihypertensive activities of Hydralazine.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C04AA01, isoxsuprine, Isoxsuprine may decrease the antihypertensive activities of Hydralazine.]
[S01AA24, kanamycin, Hydralazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Ketamine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C02KD01, ketanserin, Hydralazine may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, Hydralazine may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Hydralazine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the antihypertensive activities of Hydralazine.]
[C01CA22, arbutamine, Arbutamine may decrease the antihypertensive activities of Hydralazine.]
[N04BC09, rotigotine, Rotigotine may decrease the antihypertensive activities of Hydralazine.]
[C07AG01, labetalol, Labetalol may increase the hypotensive activities of Hydralazine.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C02AA05, deserpidine, Deserpidine may increase the hypotensive activities of Hydralazine.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Hydralazine.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Hydralazine is combined with Levodopa.]
[S01AA21, amikacin, Hydralazine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Hydralazine.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, Lisuride may decrease the antihypertensive activities of Hydralazine.]
[N06AA07, lofepramine, Lofepramine may decrease the antihypertensive activities of Hydralazine.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Hydralazine.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Hydralazine.]
[B05XA11, magnesium chloride, Hydralazine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Hydralazine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Hydralazine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Hydralazine.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may increase the hypotensive activities of Hydralazine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the antihypertensive activities of Hydralazine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Hydralazine.]
[C01CA11, mephentermine, Mephentermine may decrease the antihypertensive activities of Hydralazine.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Hydralazine.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G04BX16, tiopronin, Hydralazine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Paliperidone may decrease the antihypertensive activities of Hydralazine.]
[C01CA09, metaraminol, Metaraminol may decrease the antihypertensive activities of Hydralazine.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the antihypertensive activities of Hydralazine.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, Metergoline may decrease the antihypertensive activities of Hydralazine.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L01BA04, pemetrexed, Hydralazine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Hydralazine.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Hydralazine.]
[N05AA02, methotrimeprazine, Methotrimeprazine may decrease the antihypertensive activities of Hydralazine.]
[C01CA10, methoxamine, Methoxamine may decrease the antihypertensive activities of Hydralazine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02BG09, methoxyflurane, Methoxyflurane may decrease the antihypertensive activities of Hydralazine.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Hydralazine can be increased when used in combination with Methyclothiazide.]
[C02AB01, methyldopa, Methyldopa may increase the hypotensive activities of Hydralazine.]
[V04CG05, methylene blue, Methylene blue may increase the hypotensive activities of Hydralazine.]
[G02AB01, methylergonovine, Methylergometrine may decrease the antihypertensive activities of Hydralazine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Hydralazine.]
[N06BA04, methylphenidate, Methylphenidate may decrease the antihypertensive activities of Hydralazine.]
[G03EK01, methyltestosterone, Hydralazine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N02CA04, methysergide, The metabolism of Methysergide can be decreased when combined with Hydralazine.]
[A03FA01, metoclopramide, Metoclopramide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may increase the hypotensive activities of Hydralazine.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06AX03, mianserin, Mianserin may decrease the antihypertensive activities of Hydralazine.]
[N02BB03, aminopyrine, Aminophenazone may decrease the antihypertensive activities of Hydralazine.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Hydralazine.]
[C01CA17, midodrine, Midodrine may decrease the antihypertensive activities of Hydralazine.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C09CA03, valsartan, Valsartan may increase the hypotensive activities of Hydralazine.]
[D11AX01, minoxidil, Minoxidil may increase the hypotensive activities of Hydralazine.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the antihypertensive activities of Hydralazine.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydralazine.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Hydralazine.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be decreased when combined with Hydralazine.]
[N06AA09, amitriptyline, Amitriptyline may decrease the antihypertensive activities of Hydralazine.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Hydralazine.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Hydralazine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Hydralazine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Hydralazine.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Hydralazine.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Hydralazine is combined with Silodosin.]
[N06AA17, amoxapine, Amoxapine may decrease the antihypertensive activities of Hydralazine.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Hydralazine.]
[C07AA12, nadolol, Nadolol may increase the hypotensive activities of Hydralazine.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydralazine.]
[V03AB15, naloxone, Naloxone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[S01GA01, naphazoline, Naphazoline may decrease the antihypertensive activities of Hydralazine.]
[N06BA01, amphetamine, Amphetamine may decrease the antihypertensive activities of Hydralazine.]
[M02AA12, naproxen, Naproxen may decrease the antihypertensive activities of Hydralazine.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Hydralazine is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Hydralazine.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Hydralazine.]
[S03AA01, neomycin, Hydralazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, Remifentanil may decrease the antihypertensive activities of Hydralazine.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Levosimendan is combined with Hydralazine.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Hydralazine.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Hydralazine.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L03AX16, plerixafor, Hydralazine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Hydralazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Hydralazine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, Telmisartan may increase the hypotensive activities of Hydralazine.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01CE01, inamrinone, Hydralazine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N06AF02, nialamide, Nialamide may increase the hypotensive activities of Hydralazine.]
[C08CA04, nicardipine, Nicardipine may increase the hypotensive activities of Hydralazine.]
[C04AE02, nicergoline, Nicergoline may decrease the antihypertensive activities of Hydralazine.]
[C08CA05, nifedipine, The risk or severity of adverse effects can be increased when Nifedipine is combined with Hydralazine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the antihypertensive activities of Hydralazine.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Hydralazine is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the hypotensive activities of Hydralazine.]
[C08CA07, nisoldipine, Nisoldipine may increase the hypotensive activities of Hydralazine.]
[C08CA08, nitrendipine, Nitrendipine may increase the hypotensive activities of Hydralazine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Hydralazine.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Hydralazine.]
[C02DD01, nitroprusside, Nitroprusside may increase the hypotensive activities of Hydralazine.]
[N01AX13, nitrous oxide, Nitrous oxide may decrease the antihypertensive activities of Hydralazine.]
[C01CA03, norepinephrine, Norepinephrine may decrease the antihypertensive activities of Hydralazine.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Hydralazine.]
[C02KX01, bosentan, Bosentan may increase the hypotensive activities of Hydralazine.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Hydralazine.]
[G02CA02, nylidrin, Nylidrin may decrease the antihypertensive activities of Hydralazine.]
[N06AA05, opipramol, Opipramol may decrease the antihypertensive activities of Hydralazine.]
[N02AA02, opium, Hydralazine may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CB03, metaproterenol, Orciprenaline may decrease the antihypertensive activities of Hydralazine.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Hydralazine.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C07AA02, oxprenolol, Hydralazine may increase the hypotensive activities of Oxprenolol.]
[C01DX03, oxyfedrine, Oxyfedrine may decrease the antihypertensive activities of Hydralazine.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Hydralazine can be decreased when used in combination with Oxymetazoline.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the antihypertensive activities of Hydralazine.]
[N05AH05, asenapine, Asenapine may decrease the antihypertensive activities of Hydralazine.]
[J04AB30, capreomycin, Hydralazine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Papaverine is combined with Hydralazine.]
[C02KC01, pargyline, Pargyline may increase the hypotensive activities of Hydralazine.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G04BD11, fesoterodine, Hydralazine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Hydralazine may increase the hypotensive activities of Penbutolol.]
[J01CE09, penicillin G procaine, Hydralazine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Hydralazine.]
[L01XX08, pentostatin, Hydralazine may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Hydralazine.]
[N04BC02, pergolide, Pergolide may decrease the antihypertensive activities of Hydralazine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the hypotensive activities of Hydralazine.]
[N03AA02, phenobarbital, Phenobarbital may increase the hypotensive activities of Hydralazine.]
[C04AX02, phenoxybenzamine, Phenoxybenzamine may decrease the antihypertensive activities of Hydralazine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Hydralazine.]
[A08AA01, phentermine, Phentermine may decrease the antihypertensive activities of Hydralazine.]
[V03AB36, phentolamine, Phentolamine may decrease the antihypertensive activities of Hydralazine.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the antihypertensive activities of Hydralazine.]
[S01GA05, phenylephrine, Phenylephrine may decrease the antihypertensive activities of Hydralazine.]
[R01BA01, phenylpropanolamine, Phenylpropanolamine may decrease the antihypertensive activities of Hydralazine.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Hydralazine.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C08CX01, mibefradil, Hydralazine may increase the hypotensive activities of Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Hydralazine.]
[C07AA03, pindolol, Pindolol may increase the hypotensive activities of Hydralazine.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Hydralazine.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N06BX03, piracetam, Hydralazine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, Eprosartan may increase the hypotensive activities of Hydralazine.]
[S01BC06, piroxicam, Piroxicam may decrease the antihypertensive activities of Hydralazine.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N02CX01, pizotyline, Pizotifen may decrease the antihypertensive activities of Hydralazine.]
[C09CA04, irbesartan, Irbesartan may increase the hypotensive activities of Hydralazine.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA05, polythiazide, The therapeutic efficacy of Hydralazine can be increased when used in combination with Polythiazide.]
[A10BH03, saxagliptin, Hydralazine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C07AB01, practolol, Hydralazine may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Hydralazine.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Hydralazine.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01BA02, procainamide, Hydralazine may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, Procaine may increase the hypotensive activities of Hydralazine.]
[L01XB01, procarbazine, Procarbazine may increase the hypotensive activities of Hydralazine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Hydralazine.]
[N05AA03, promazine, Promazine may decrease the antihypertensive activities of Hydralazine.]
[R06AD02, promethazine, Promethazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01BC03, propafenone, Propafenone may decrease the antihypertensive activities of Hydralazine.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[N05AC01, periciazine, Periciazine may decrease the antihypertensive activities of Hydralazine.]
[N05CM06, propiomazine, Propiomazine may decrease the antihypertensive activities of Hydralazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Hydralazine.]
[N01AX10, propofol, Propofol may decrease the antihypertensive activities of Hydralazine.]
[C07AA05, propranolol, Propranolol may increase the hypotensive activities of Hydralazine.]
[N02CC04, rizatriptan, Rizatriptan may decrease the antihypertensive activities of Hydralazine.]
[B01AC09, epoprostenol, Epoprostenol may increase the hypotensive activities of Hydralazine.]
[N06AA11, protriptyline, Protriptyline may decrease the antihypertensive activities of Hydralazine.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the antihypertensive activities of Hydralazine.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Hydralazine.]
[N07XX07, dalfampridine, Hydralazine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Hydralazine may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Hydralazine.]
[P01BC01, quinine, Quinine may increase the hypotensive activities of Hydralazine.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C02AA01, rescinnamine, Rescinnamine may decrease the antihypertensive activities of Hydralazine.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[R03AC05, rimiterol, Rimiterol may decrease the antihypertensive activities of Hydralazine.]
[G02CA01, ritodrine, Ritodrine may decrease the antihypertensive activities of Hydralazine.]
[N02BA05, salicylamide, Salicylamide may decrease the antihypertensive activities of Hydralazine.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the antihypertensive activities of Hydralazine.]
[S01BC08, salicylic acid, Salicylic acid may decrease the antihypertensive activities of Hydralazine.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Hydralazine.]
[N04BD01, selegiline, Selegiline may increase the hypotensive activities of Hydralazine.]
[L01FA03, obinutuzumab, Hydralazine may increase the hypotensive activities of Obinutuzumab.]
[J01GB08, sisomicin, Hydralazine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Hydralazine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Hydralazine may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Hydralazine.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Hydralazine.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DA14, isosorbide mononitrate, Hydralazine may increase the vasodilatory activities of Isosorbide mononitrate.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the antihypertensive activities of Hydralazine.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
